Renalytix (LSE:RENX) 6-Month Share Buyback Ratio : -114.56% (As of Dec. 2024 )

View and export this data going back to 2018. Start your Free Trial

What is Renalytix 6-Month Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Renalytix's current 6-Month Share Buyback Ratio was -114.56%.

Competitive Comparison of Renalytix's 6-Month Share Buyback Ratio

For the Health Information Services subindustry, Renalytix's 6-Month Share Buyback Ratio, along with its competitors' market caps and 6-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renalytix's 6-Month Share Buyback Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Renalytix's 6-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Renalytix's 6-Month Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Renalytix 6-Month Share Buyback Ratio Calculation

Renalytix's 6-Month Share Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

6-Month Share Buyback Ratio	=	(Shares Outstanding (EOP) (Jun. 2024 )	-	Shares Outstanding (EOP) (Dec. 2024 ))	/	Shares Outstanding (EOP) (Jun. 2024 )
	=	(154.368	-	331.206)	/	154.368
	=	-114.56%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renalytix (LSE:RENX) 6-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Renalytix 6-Month Share Buyback Ratio Related Terms

Renalytix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » 6-Month Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

RNLXY:USA RENXF:USA 2O9:Germany

Address

2 Leman Street, London, GBR, E1W 9US

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix Headlines

From GuruFocus

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe • 08-29-2013

Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.

By PRNewswire PRNewswire • 03-27-2018

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex • 12-14-2012

Investing in Information

By Vanina Egea Vanina Egea • 03-06-2014